After two or more weeks without administration, restarting at the full maintenance dose risks severe gastrointestinal distress because receptor adaptation has partially reversed
Mounjaro, on the other hand, is the brand name for Tirzepatide, a somewhat newer medication that not only agonizes the GLP-1 receptor but also targets GIP (Glucose-dependent Insulinotropic Polypeptide) receptors, offering a dual mechanism of action
Some patients report success on second or third appeals, especially when the clinical case is strengthened with additional documentation
Dose cycling for plateaus Weight loss plateaus are common with any metabolic intervention
Nutrition & Muscle Support Guidance on adequate protein, balanced nutrition, and resistance activity to help protect lean muscle mass an important consideration during any medically supervised weight loss
Liraglutide for weight management: a critical review of the evidence